In the US, Depakote (divalproex sodium systemic) is a member of the drug class fatty acid derivative anticonvulsants and is used to treat Bipolar Disorder, Epilepsy, Mania and Migraine Prevention.
US matches:
- Depakote
- Depakote Delayed-Release Tablets
- Depakote ER Extended-Release Tablets
- Depakote Sprinkle Capsules
- Depakote ER
- Depakote Sprinkles
- Depakote DR
- Depakote Capsules
UK matches:
- Depakote tablets (SPC)
Ingredient matches for Depakote
Valproic Acid
Valproic Acid semisodium (a derivative of Valproic Acid) is reported as an ingredient of Depakote in the following countries:
- Antigua & Barbuda
- Aruba
- Bahamas
- Barbados
- Bermuda
- Brazil
- Cayman Islands
- Grenada
- Guyana
- Haiti
- Indonesia
- Jamaica
- Luxembourg
- Netherlands Antilles
- Philippines
- Saint Lucia
- Saint Vincent & The Grenadines
- Suriname
- Trinidad & Tobago
- Turks & Caicos Islands
- United Kingdom
- United States
- Virgin Islands (British)
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Depakote in the following countries:
- United Kingdom
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment